Mark Goodman

Associate Professor of Clinical

  • 527 Citations

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Mark Goodman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 527 Citations
  • 18 Article
  • 4 Review article
  • 2 Letter

Incidence and risk factors associated with a syndrome of persistent cytopenias after CAR-T cell therapy (PCTT)

Nahas, G. R., Komanduri, K. V., Pereira, D., Goodman, M., Jimenez, A. M., Beitinjaneh, A., Wang, T. P. & Lekakis, L. J., Mar 20 2020, In : Leukemia and Lymphoma. 61, 4, p. 940-943 4 p.

Research output: Contribution to journalArticle

  • 1 Scopus citations
  • 11 Scopus citations
  • 7 Scopus citations

    Routine interim disease assessment in patients undergoing induction chemotherapy for acute myeloid leukemia: Can we do better?

    Campuzano-Zuluaga, G., Deutsch, Y., Salzberg, M., Gomez, A., Vargas, F., Elias, R., Kwon, D., Goodman, M., Ikpatt, O. F., Chapman, J. R., Watts, J., Vega, F. & Swords, R., Mar 1 2016, In : American Journal of Hematology. 91, 3, p. 277-282 6 p.

    Research output: Contribution to journalArticle

  • 6 Scopus citations

    Phase 2 randomized study of p53 antisense oligonucleotide (cenersen) plus idarubicin with or without cytarabine in refractory and relapsed acute myeloid leukemia

    Cortes, J., Kantarjian, H., Ball, E. D., DiPersio, J., Kolitz, J. E., Fernandez, H. F., Goodman, M., Borthakur, G., Baer, M. R. & Wetzler, M., Jan 15 2012, In : Cancer. 118, 2, p. 418-427 10 p.

    Research output: Contribution to journalArticle

  • 21 Scopus citations